These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17534979)

  • 1. RhDNase before airway clearance therapy improves airway patency in children with CF.
    van der Giessen LJ; de Jongste JC; Gosselink R; Hop WC; Tiddens HA
    Pediatr Pulmonol; 2007 Jul; 42(7):624-30. PubMed ID: 17534979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human DNase nebulisation in children with cystic fibrosis: before bedtime or after waking up?
    van der Giessen LJ; Gosselink R; Hop WC; Tiddens HA
    Eur Respir J; 2007 Oct; 30(4):763-8. PubMed ID: 17596273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rhDNase on airflow obstruction and mucociliary clearance in cystic fibrosis.
    Laube BL; Auci RM; Shields DE; Christiansen DH; Lucas MK; Fuchs HJ; Rosenstein BJ
    Am J Respir Crit Care Med; 1996 Feb; 153(2):752-60. PubMed ID: 8564129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The timing of rhDNase in relation to airway clearance therapy-unplugged.
    Tannenbaum EL; Ranganathan S
    Pediatr Pulmonol; 2007 Dec; 42(12):1235; author reply 1236-7. PubMed ID: 17708574
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
    Fuchs HJ; Borowitz DS; Christiansen DH; Morris EM; Nash ML; Ramsey BW; Rosenstein BJ; Smith AL; Wohl ME
    N Engl J Med; 1994 Sep; 331(10):637-42. PubMed ID: 7503821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a short course of rhDNase on cough and mucociliary clearance in patients with cystic fibrosis.
    Robinson M; Hemming AL; Moriarty C; Eberl S; Bye PT
    Pediatr Pulmonol; 2000 Jul; 30(1):16-24. PubMed ID: 10862158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of inhaled mannitol, daily rhDNase and a combination of both in children with cystic fibrosis: a randomised trial.
    Minasian C; Wallis C; Metcalfe C; Bush A
    Thorax; 2010 Jan; 65(1):51-6. PubMed ID: 19996349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis.
    Ramsey BW; Astley SJ; Aitken ML; Burke W; Colin AA; Dorkin HL; Eisenberg JD; Gibson RL; Harwood IR; Schidlow DV
    Am Rev Respir Dis; 1993 Jul; 148(1):145-51. PubMed ID: 8317790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatment.
    Shah PI; Bush A; Canny GJ; Colin AA; Fuchs HJ; Geddes DM; Johnson CA; Light MC; Scott SF; Tullis DE
    Eur Respir J; 1995 Jun; 8(6):954-8. PubMed ID: 7589382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of human deoxyribonuclease (rhDNase) in the management of cystic fibrosis.
    Suri R
    BioDrugs; 2005; 19(3):135-44. PubMed ID: 15984899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human DNase in children with airway malacia and lower respiratory tract infection.
    Boogaard R; de Jongste JC; Vaessen-Verberne AA; Hop WC; Merkus PJ
    Pediatr Pulmonol; 2009 Oct; 44(10):962-9. PubMed ID: 19768804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bolus inhalation of rhDNase with the AERx system in subjects with cystic fibrosis.
    Geller D; Thipphawong J; Otulana B; Caplan D; Ericson D; Milgram L; Okikawa J; Quan J; Bowman CM
    J Aerosol Med; 2003; 16(2):175-82. PubMed ID: 12823911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airway inflammation after treatment with aerosolized deoxyribonuclease in cystic fibrosis.
    Henry RL; Gibson PG; Carty K; Cai Y; Francis JL
    Pediatr Pulmonol; 1998 Aug; 26(2):97-100. PubMed ID: 9727759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Socioeconomic evaluation of the effect of rhDNase on the cost of treating infections of the respiratory tract in patients with cystic fibrosis].
    von der Schulenburg JM; Greiner W; von der Hardt H
    Med Klin (Munich); 1995 Apr; 90(4):220-4. PubMed ID: 7776934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNase in stable cystic fibrosis infants: a pilot study.
    Berge MT; Wiel Ev; Tiddens HA; Merkus PJ; Hop WC; de Jongste JC
    J Cyst Fibros; 2003 Dec; 2(4):183-8. PubMed ID: 15463871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis.
    Suri R; Metcalfe C; Wallis C; Bush A
    Pediatr Pulmonol; 2004 Apr; 37(4):305-10. PubMed ID: 15022126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of recombinant human DNase and hypertonic saline on airway inflammation in children with cystic fibrosis.
    Suri R; Marshall LJ; Wallis C; Metcalfe C; Bush A; Shute JK
    Am J Respir Crit Care Med; 2002 Aug; 166(3):352-5. PubMed ID: 12153969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of magnesium in the failure of rhDNase therapy in patients with cystic fibrosis.
    Sanders NN; Franckx H; De Boeck K; Haustraete J; De Smedt SC; Demeester J
    Thorax; 2006 Nov; 61(11):962-8. PubMed ID: 17071834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is a longer time interval between recombinant human deoxyribonuclease (dornase alfa) and chest physiotherapy better? A multi-center, randomized crossover trial.
    Wilson CJ; Robbins LJ; Murphy JM; Chang AB
    Pediatr Pulmonol; 2007 Dec; 42(12):1110-6. PubMed ID: 17955550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of PEGylation on the mucolytic activity of recombinant human deoxyribonuclease I in cystic fibrosis sputum.
    Guichard MJ; Kinoo D; Aubriot AS; Bauwens N; Gougué J; Vermeulen F; Lebecque P; Leal T; Vanbever R
    Clin Sci (Lond); 2018 Jul; 132(13):1439-1452. PubMed ID: 29871879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.